|
GB201811375D0
|
|
Treatment of autoimmune disease
|
|
GB201809835D0
|
|
Treatment of gastrointestinal disease
|
|
GB201808964D0
|
|
Treatment of liver disease
|
|
GB201517132D0
|
|
New pharmaceutical use
|
|
GB201517133D0
|
|
New pharmaceutical use
|
|
GB201508613D0
|
|
New pharmaceutical use
|
|
GB201507902D0
|
|
New pharmaceutical use
|
|
GB201507813D0
|
|
New pharmaceutical use
|
|
GB201411148D0
|
|
New pharmaceutical uses
|
|
GB201408432D0
|
|
Pharmaceutical compositions
|
|
GB201320349D0
|
|
New therapeutic use
|
|
GB201208315D0
|
|
Pharmaceutical methods and compositions
|
|
GB201120735D0
|
|
New pharmaceutical uses
|
|
GB201106520D0
|
|
Pharmaceutical compounds
|
|
GB201001216D0
|
|
Pharmaceutical compounds
|
|
GB0921139D0
|
|
Pharmaceutical methods & compositions
|
|
GB0917677D0
|
|
Pharmaceutical compounds
|
|
GB0915678D0
|
|
Pharmaceutical compounds
|
|
GB0913850D0
|
|
Pharmaceutical compounds
|
|
GB0902428D0
|
|
Pharmaceutical methods & compositions
|
